Charles River Laboratories International (CRL) Cash from Discontinued Operations (2009 - 2018)
Charles River Laboratories International (CRL) posted Cash from Discontinued Operations of -$4000.0 for Q3 2018, up 99.87% on a QoQ basis from -$3.1 million in Q2 2018, and up 99.19% year-over-year from -$2008.2 in Q3 2017.
Analysis
Charles River Laboratories International (CRL) Cash from Discontinued Operations (2009 - 2018) Analysis & Trends
Charles River Laboratories International has reported Cash from Discontinued Operations for 10 years, with the latest figure at -$4000.0 in Q3 2018.
- On a quarterly basis, Cash from Discontinued Operations rose 99.19% year-over-year to -$4000.0 in Q3 2018; TTM through Jun 2019 was -$4000.0, a 99.91% increase from a year earlier, with the FY2018 full-year figure at -$3.7 million, down 106.47% from the prior year.
- Cash from Discontinued Operations was -$4000.0 for Q3 2018 at Charles River Laboratories International, up from -$3.1 million in the prior quarter.
- The five-year high for Cash from Discontinued Operations was $119000.0 in Q3 2014, with the low at -$3.1 million in Q2 2018.
- Average Cash from Discontinued Operations over 5 years is -$555631.6, with a median of -$492000.0 recorded in 2017.
- The largest YoY upside for Cash from Discontinued Operations was 120.27% in 2014 against a maximum downside of 22033.33% in 2014.
- Over 5 years, Cash from Discontinued Operations stood at -$511000.0 in 2014, then fell by 19.57% to -$611000.0 in 2015, then fell by 1.8% to -$622000.0 in 2016, then jumped by 48.55% to -$320000.0 in 2017, then jumped by 98.75% to -$4000.0 in 2018.
- The last three Cash from Discontinued Operations figures came in at -$4000.0 (Q3 2018), -$3.1 million (Q2 2018), and -$636000.0 (Q1 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -2.10 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.90 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 29, 2018 | -4,000.00 |
| Jun 30, 2018 | -3.10 Mn |
| Mar 31, 2018 | -636,000.00 |
| Dec 30, 2017 | -320,000.00 |
| Sep 30, 2017 | -492,000.00 |
| Jul 1, 2017 | -524,000.00 |
| Apr 1, 2017 | -473,000.00 |
| Dec 31, 2016 | -622,000.00 |
| Sep 24, 2016 | -652,000.00 |
| Jun 25, 2016 | -293,000.00 |
| Mar 26, 2016 | -489,000.00 |
| Dec 26, 2015 | -611,000.00 |
| Sep 26, 2015 | -338,000.00 |
| Jun 27, 2015 | -611,000.00 |
| Mar 28, 2015 | -316,000.00 |
| Dec 27, 2014 | -511,000.00 |
| Sep 27, 2014 | 119,000.00 |
| Jun 28, 2014 | -25,000.00 |
| Mar 29, 2014 | -664,000.00 |
| Dec 28, 2013 | -373,000.00 |